UBS Group AG - ARTELO BIOSCIENCES INC ownership

ARTELO BIOSCIENCES INC's ticker is ARTLW and the CUSIP is 04301G128. A total of 4 filers reported holding ARTELO BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ARTELO BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$4
-91.7%
100
-85.4%
0.00%
Q1 2023$48
-85.4%
687
-91.6%
0.00%
Q4 2022$3298,223
+2745.3%
0.00%
Q2 2022$0289
-0.3%
0.00%
Q1 2022$0290
+45.0%
0.00%
Q4 2021$0
-100.0%
200
-95.4%
0.00%
Q3 2021$1,000
-50.0%
4,377
-4.2%
0.00%
Q2 2021$2,0004,5670.00%
Other shareholders
ARTELO BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
UBS Group AG 100$40.00%
BANK OF AMERICA CORP /DE/ 100$40.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 162$60.00%
Verition Fund Management LLC 27,299$1,3190.00%
Alpine Global Management, LLC 14,099$5650.00%
View complete list of ARTELO BIOSCIENCES INC shareholders